The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
AQST · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | AQST | LIVN | KRMD | SRPT |
|---|---|---|---|---|
| Moat Score (0–100) | 49 (highest) | 49 (highest) | 49 (highest) | 49 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 24 | 60 (highest) | 60 (highest) | 60 (highest) |
| Pricing power | 93 | 98 | 98 | 100 (highest) |
| Returns on capital | — | 4 | 7 (highest) | 5 |
| Balance-sheet safety | 55 | 60 (highest) | 55 | 55 |
| Capital allocation | 24 (highest) | 24 (highest) | 24 (highest) | 24 (highest) |
| No price data | No price data | No price data | No price data | |
| Market cap | $449M | $4.3B | $178M | $1.6B |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |